Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$32.87 - $43.55 $1.05 Million - $1.39 Million
-32,017 Reduced 53.64%
27,667 $925,000
Q1 2024

May 10, 2024

BUY
$37.88 - $43.77 $648,884 - $749,780
17,130 Added 40.25%
59,684 $2.55 Million
Q4 2023

Feb 13, 2024

BUY
$31.71 - $38.95 $1.35 Million - $1.66 Million
42,554 New
42,554 $1.65 Million
Q2 2023

Aug 14, 2023

BUY
$39.98 - $47.68 $477,681 - $569,680
11,948 New
11,948 $544,000
Q4 2022

Feb 14, 2023

SELL
$49.7 - $57.71 $1.64 Million - $1.9 Million
-32,901 Reduced 74.33%
11,361 $579,000
Q3 2022

Feb 14, 2023

BUY
$53.86 - $66.8 $1.18 Million - $1.47 Million
22,001 Added 98.83%
44,262 $2.38 Million
Q2 2022

Aug 08, 2022

BUY
$63.83 - $80.0 $1.42 Million - $1.78 Million
22,261 New
22,261 $1.43 Million
Q3 2021

Nov 15, 2021

SELL
$73.77 - $83.61 $559,102 - $633,680
-7,579 Closed
0 $0
Q2 2021

Aug 26, 2021

BUY
$80.5 - $88.01 $610,109 - $667,027
7,579 New
7,579 $610,000
Q2 2021

Aug 12, 2021

SELL
$80.5 - $88.01 $2.62 Million - $2.86 Million
-32,544 Closed
0 $610,000
Q1 2021

May 12, 2021

BUY
$76.38 - $86.03 $2.49 Million - $2.8 Million
32,544 New
32,544 $2.79 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.